Taking Control Of Your Diabetes® - The Podcast!

A Sit Down with Breakthrough T1D's (Formerly JDRF) CEO Aaron Kowalski

Taking Control Of Your Diabetes® - The Podcast!

Show Notes

A Sit Down with Breakthrough T1D (Formerly JDRF) – Featuring Aaron Kowalski, CEO TAKING CONTROL OF YOUR DIABETES® - THE PODCAST! ...With Expert Endocrinologists Living with T1D, Drs. Steven V. Edelman & Jeremy Pettus This special edition of the Taking Control of Your Diabetes podcast is an enlightening conversation between three diabetes experts all living with type 1 diabetes themselves: Dr. Steve Edelman, Dr. Jeremy Pettus, and Dr. Aaron Kowalski, CEO of Breakthrough T1D (formerly JDRF) . They discuss recent research breakthroughs in type 1 diabetes, focusing on three main areas: improving lives through technology and medications, disease-modifying therapies to address the autoimmune nature of type 1 diabetes, and cellular replacement therapies. The conversation highlights advancements in hybrid closed-loop systems, emerging drugs for better glucose control, screening for early detection, and promising stem cell research that could lead to a cure. Dr. Kowalski expresses optimism about the future, suggesting that cell therapy products could be available within this decade, potentially allowing some people with type 1 diabetes to stop requiring insulin.

Key topics include: Who is Aaron Kowalski and how did he become the CEO of Breakthrough T1D? What is the history of JDRF, and why did the name change? What is the mission of Breakthrough T1D? The three main types of goals/research at Breakthrough T1D: Improving the lives of those with type 1 diabetes, Disease-modifying therapies, Сell replacement therapies What is the importance of getting screened for T1D? How has technology for diabetes evolved? Will there ever be a cure for T1D? How can cellular replacement therapies help us find a cure for T1D? Breakthrough T1D (formerly JDRF) accelerates life-changing breakthroughs for type 1 diabetes through multiple approaches. They fund and drive research in three main areas: improving daily life with diabetes through technology and medication advancements, developing disease-modifying therapies to address the autoimmune nature of type 1 diabetes, and advancing cell replacement therapies, particularly stem cell-derived islet cells. Additionally, they focus on screening initiatives to identify at-risk individuals, advocate for broader access to treatments and clinical trials, educate the community and healthcare providers about new developments, and partner with pharmaceutical companies and research institutions. Their overarching goal is to drive towards curing type 1 diabetes while simultaneously making everyday life easier for those living with the condition.

Follow Breakthrough T1D: Instagram: https://www.instagram.com/breakthrought1dhq/ Facebook: https://www.facebook.com/breakthrought1dhq X: https://x.com/BreakthroughT1D Linkedin: https://www.linkedin.com/company/breakthrought1d/posts/?feedView=all Visit Breakthrough T1D Website: https://www.breakthrought1d.org/ Connect with Aaron Kowalski, CEO of Breakthrough T1D: https://www.linkedin.com/in/aaron-kowalski-3221a35/ Useful links to discover: TCOYD Podcast - Why Everyone Should Screen for Type 1: https://tcoydthepodcast.transistor.fm/55 TCOYD Article: https://tcoyd.org/2024/06/an-endocrinologists-journey-helping-with-people-living-with-type-1-diabetes/

Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: https://tcoyd.org/ **Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!**

Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook: https://www.facebook.com/TCOYD/ Instagram: https://www.instagram.com/tcoyd/ YouTube: https://www.youtube.com/channel/UC4WWhIDg18gP9ZC-IeqmYNQ

★ Support this podcast ★

More from Taking Control Of Your Diabetes® - The Podcast!

Oct 8, 2026

What if you could take your basal insulin once a week instead of every day? Once-weekly basal insulin has arrived, offering a new approach that could make insulin therapy simpler while providing glucose control comparable to daily basal insulin. In this episode, Dr. Steve Edelman is joined by Dr. Athena Philis-Tsimikas, a leading diabetes researcher who has been directly involved in clinical trials of once-weekly basal insulins. Together, they explain how these ultra-long-acting insulins work, how a single injection can provide steady background insulin throughout an entire week, and what studies have shown when once-weekly insulin is compared with traditional daily basal insulin. The conversation gets practical with how once-weekly insulin is started, adjusted, and switched from daily basal insulin. Dr. Edelman and Dr. Philis-Tsimikas discuss the dosage differences with once-weekly basal insulin, how concentrated insulin keeps the actual injection volume small, and how fasting glucose can help guide dose adjustments. They also discuss what happens if you miss a dose and why reaching a steady state is an important part of understanding how these longer-acting insulins work. They also dive into the clinical trial results, including A1C, time in range, and hypoglycemia. In studies of people living with type 2 diabetes, once-weekly basal insulin provided similar A1C lowering to daily basal insulin without an increase in hypoglycemia. They also explain why the story is different for people living with type 1 diabetes, where studies found higher rates of hypoglycemia with weekly basal insulin, and what that means for its use in the United States. Finally, Dr. Edelman and Dr. Philis-Tsimikas look at how once-weekly insulin could make diabetes management easier. Going from seven basal injections a week to just one could help reduce some of the daily burden of diabetes and make it easier to consistently take your insulin. They also explore using weekly insulin alongside GLP-1 medications, potential combination therapies, cost and access, and what we still need to learn as these newer insulins move from clinical trials into everyday diabetes care. Key Topics: How once-weekly basal insulin works Once-weekly vs. daily basal insulin Starting, dosing, and adjusting weekly insulin Why weekly insulin doses may look surprisingly large A1C, time in range, and hypoglycemia results What to do if you miss a weekly dose Once-weekly insulin in type 1 vs. type 2 diabetes Who may benefit from once-weekly insulin? Reducing the burden of daily injections Using once-weekly insulin with GLP-1 medications Future insulin and GLP-1 combination therapies Cost, access, and real-world considerations What the future of basal insulin could look like This episode was supported by Lilly. ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

Sep 28, 2026

Managing type 2 diabetes can change over time, but having the right information for your patients can make those changes feel a lot more manageable. CGM can help your patients see what’s happening with their blood sugar and guide what comes next.

Sep 8, 2026

Chronic kidney disease (CKD) is one of the most common complications of diabetes, but here’s the tricky part: you can have it for years without feeling any symptoms. The good news? Kidney disease can often be detected early, and with the right screening, treatments, and lifestyle changes, its progression can be dramatically slowed. In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus are joined by nephrologist Dr. Bethany Karl to break down what everyone with diabetes should know about kidney health. Dr. E also steps into the patient seat to share his own experience living with chronic kidney disease, from discovering it without symptoms to navigating kidney tests and newer treatments. Together, they explain the two simple tests that can uncover kidney problems, why blood pressure and cardiovascular health matter, and how today’s growing toolbox of medications is giving people with diabetic kidney disease more reasons for hope.

Aug 25, 2026

Hot flashes, blood sugar swings, brain fog... is it menopause, diabetes, or both?

Aug 10, 2026

Have you or someone you know been diagnosed with type 2 diabetes, only to discover later it was actually type 1? You're not alone.

See all episodes →